Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32678431 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL32678430 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL238102 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL19924614 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL30797151 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL5157013 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL238100 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL11247489 | 0.85 | EPHX1 (0.53) | EPHX1 | |
| SCHEMBL11251253 | 0.78 | EPHX1 (0.35) | EPHX1 | |
| Triethyl Citrate SCHEMBL1326007 | 0.75 | CYP2D6 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1028 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4214303-B1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2026-05-06 | — | — | EP | claimed |
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| US-12522786-B2 | Organic compounds | GIVAUDAN SA (CH) | 2026-01-13 | — | — | US | claimed |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-12-16 | — | — | US | claimed |
| US-20250344991-A1 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | UNIV ROCKEFELLER (US) | 2025-11-13 | — | — | US | claimed |
| US-20250302728-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2025-10-02 | — | — | US | claimed |
| WO-2025202258-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-10-02 | — | — | WO | claimed |
| EP-3648613-B1 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | UNIV ROCKEFELLER (US) | 2025-09-24 | — | — | EP | claimed |
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-09-18 | — | — | US | claimed |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | claimed |
| US-20100168251-A1 | FRAGRANCE COMPOSITION FOR CORE SHELL MICROCAPSULES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-07-01 | — | — | US | claimed |
| WO-2009124888-A1 | USE OF CARBOXYLIC ACID ESTERS AS A FRAGRANCE SUBSTANCE | SYMRISE GMBH & CO. KG (DE) | 2009-10-15 | — | — | WO | claimed |
| EP-2014273-A1 | Use of methyl methyl ether and another ether to provide a feeling of cleanliness and purity | Symrise GmbH & Co. KG (DE) | 2009-01-14 | — | — | EP | claimed |
| US-7399318-B2 | Stable composition for hair dye | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-07-15 | — | — | US | claimed |
| EP-1714637-A2 | Stable composition for hair dye comprising a fragrance | Takasago International Corporation (JP) | 2006-10-25 | — | — | EP | claimed |
| US-20060218730-A1 | Stable composition for hair dye | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-10-05 | — | — | US | claimed |
| US-6322838-B1 | Mint and/or fruit flavor compositions | HAARMANN & REIMER GMBH (DE) | 2001-11-27 | — | — | US | claimed |
| WO-1995000040-A1 | STABILISING VOLATILE FLAVOURINGS | FIRMENICH SA (CH) | 1995-01-05 | — | — | WO | claimed |
| US-4262030-A | 1,3-OXATHIANE AND 1,3-OXATHIOLANE DERIVATIVES | FIRMENICH SA (CH) | 1981-04-14 | — | — | US | claimed |
| US-4220561-A | Oxathiane and oxathiolane derivatives as perfuming agents | FIRMENICH SA (CH) | 1980-09-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | EPHX1 405/4885 |
| US-20100168251-A1 | FRAGRANCE COMPOSITION FOR CORE SHELL MICROCAPSULES | C5, CACNG5, COPG1 | EPHX1 747/4885 |
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | OR10J3, TRPA1, TAS2R3 | EPHX1 1708/4885 |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | EPHX1 250/4885 |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | CHRM5, NNMT, CHRM1 | EPHX1 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.